BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-571@pharmaconomics
DTSTAMP:20260707T005946Z
DTSTART;VALUE=DATE:20260930
DTEND;VALUE=DATE:20261001
SUMMARY:KOD Phase 1 — KSI-101 (estimated date)
DESCRIPTION:Phase 1 trial results for KSI-101 in macular edema secondary to inflammation (MESI) are due ~ Sep 30\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1468748/000119312526127041/d283186dex991.htm\n\nTrack it: https://www.pharmaconomics.com/e/571
URL:https://www.pharmaconomics.com/e/571
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:KOD catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR